Acutus Medical Inc (AFIB) - Net Assets
Based on the latest financial reports, Acutus Medical Inc (AFIB) has net assets worth $-11.59 Million USD as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($28.65 Million) and total liabilities ($40.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AFIB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-11.59 Million |
| % of Total Assets | -40.46% |
| Annual Growth Rate | N/A |
| 5-Year Change | -109.16% |
| 10-Year Change | N/A |
| Growth Volatility | 37.32 |
Acutus Medical Inc - Net Assets Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's net assets have evolved over time, based on quarterly financial data. Also explore AFIB asset base for the complete picture of this company's asset base.
Annual Net Assets for Acutus Medical Inc (2018–2024)
The table below shows the annual net assets of Acutus Medical Inc from 2018 to 2024. For live valuation and market cap data, see market cap of Acutus Medical Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-11.59 Million | -1218.77% |
| 2023-12-31 | $-879.00K | -101.17% |
| 2022-12-31 | $75.02 Million | -29.04% |
| 2021-12-31 | $105.73 Million | -16.48% |
| 2020-12-31 | $126.58 Million | +156.06% |
| 2019-12-31 | $-225.81 Million | -71.30% |
| 2018-12-31 | $-131.82 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Acutus Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 44752900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $30.00K | % |
| Other Comprehensive Income | $-768.00K | % |
| Other Components | $598.67 Million | % |
| Total Equity | $-11.59 Million | 100.00% |
Acutus Medical Inc Competitors by Market Cap
The table below lists competitors of Acutus Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
River and Mercantile UK Micro Cap Investment Company Ltd
LSE:RMMC
|
$903.48K |
|
Spectra Systems Corp
LSE:SPSY
|
$906.11K |
|
Teras Resources Inc
V:TRA
|
$908.19K |
|
Geneuro SA
PA:GNRO
|
$911.56K |
|
Ampli SA w upadlosci ukladowej
WAR:APL
|
$903.25K |
|
Centurion Minerals Ltd
V:CTN
|
$898.90K |
|
Vitality Products Inc
V:VPI
|
$898.69K |
|
Urbanimmersive Inc
V:UI
|
$897.04K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Acutus Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -879,000 to -11,592,000, a change of -10,713,000.
- Net loss of 9,547,000 reduced equity.
- Other comprehensive income increased equity by 98,000.
- Other factors decreased equity by 1,264,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.55 Million | -82.36% |
| Other Comprehensive Income | $98.00K | +0.85% |
| Other Changes | $-1.26 Million | -10.9% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Acutus Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-7.82 | $0.03 | x |
| 2019-12-31 | $-8.23 | $0.03 | x |
| 2020-12-31 | $11.10 | $0.03 | x |
| 2021-12-31 | $3.69 | $0.03 | x |
| 2022-12-31 | $2.63 | $0.03 | x |
| 2023-12-31 | $-0.03 | $0.03 | x |
| 2024-12-31 | $-0.39 | $0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Acutus Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.36%
- • Asset Turnover: 0.70x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-35.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -2211.77% | 0.08x | 0.00x | $-34.72 Million |
| 2019 | 0.00% | -4206.88% | 0.03x | 0.00x | $-96.73 Million |
| 2020 | -80.56% | -1204.88% | 0.04x | 1.52x | $-114.64 Million |
| 2021 | -116.68% | -714.59% | 0.10x | 1.61x | $-133.93 Million |
| 2022 | -52.81% | -242.11% | 0.12x | 1.78x | $-47.12 Million |
| 2023 | 0.00% | -1139.91% | 0.13x | 0.00x | $-81.58 Million |
| 2024 | 0.00% | -47.36% | 0.70x | 0.00x | $-8.39 Million |
Industry Comparison
This section compares Acutus Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,691,363,657
- Average return on equity (ROE) among peers: -69.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | N/A | $903.35K |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more